# FASLODEX
> **NDA021344** · New Drug Application · Sponsor: ASTRAZENECA · Approved 2002-04-25
## Drug
- **FDA Application Number:** NDA021344
- **Application type:** New Drug Application
- **Brand name:** FASLODEX
- **Generic name:** FULVESTRANT
- **Active ingredients:** FULVESTRANT
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** ASTRAZENECA
- **Manufacturer:** AstraZeneca Pharmaceuticals LP
- **First approval:** 2002-04-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021344)
---
*AI Analytics · CC0 1.0*